Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet-rich plasma versus hyaluronic acid for hip osteoarthritis
jRCTb060190038Completed
- Sponsor
- Japan Hip Joint Foundation
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of platelet-rich plasma, hyaluronic acid and lidocaine in hip osteoarthritis (2 arms), sponsored by Japan Hip Joint Foundation. Primary endpoint: Rate of change of WOMAC Pain. Started Apr 2019; status: completed.
02
Drugs
platelet-rich plasmahyaluronic acidlidocaine
03
Conditions
hip osteoarthritis
Beyond the preview
Go deeper on jRCTb060190038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTb060190038.